Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | BSX | Common Stock | Options Exercise | $0 | +16.8K | +0.91% | $0.00 | 1.86M | Feb 21, 2023 | Direct | F1 |
transaction | BSX | Common Stock | Tax liability | -$345K | -7.46K | -0.4% | $46.23 | 1.85M | Feb 21, 2023 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | BSX | Deferred Stock Units | Options Exercise | $0 | -16.8K | -100% | $0.00* | 0 | Feb 21, 2023 | Common Stock | 16.8K | Direct | F1, F2 |
Id | Content |
---|---|
F1 | Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. |
F2 | Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 21, 2020, the first anniversary of the date of grant. |